OraSure Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OSUR and other ETFs, options, and stocks.

About OSUR

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. 

CEO
Carrie Eglinton Manner
CEOCarrie Eglinton Manner
Employees
501
Employees501
Headquarters
Bethlehem, Pennsylvania
HeadquartersBethlehem, Pennsylvania
Founded
2000
Founded2000
Employees
501
Employees501

OSUR Key Statistics

Market cap
187.23M
Market cap187.23M
Price-Earnings ratio
-3.76
Price-Earnings ratio-3.76
Dividend yield
Dividend yield
Average volume
466.15K
Average volume466.15K
High today
$2.66
High today$2.66
Low today
$2.52
Low today$2.52
Open price
$2.57
Open price$2.57
Volume
441.95K
Volume441.95K
52 Week high
$4.60
52 Week high$4.60
52 Week low
$2.36
52 Week low$2.36

Stock Snapshot

The current OraSure Technologies(OSUR) stock price is $2.52, with a market capitalization of 187.23M. The stock trades at a price-to-earnings (P/E) ratio of -3.76.

On 2025-11-06, OraSure Technologies(OSUR) stock traded between a low of $2.52 and a high of $2.66. Shares are currently priced at $2.52, which is 0.0% above the low and -5.3% below the high.

OraSure Technologies(OSUR) shares are trading with a volume of 441.95K, against a daily average of 466.15K.

During the past year, OraSure Technologies(OSUR) stock moved between $2.36 at its lowest and $4.60 at its peak.

During the past year, OraSure Technologies(OSUR) stock moved between $2.36 at its lowest and $4.60 at its peak.

OSUR News

TipRanks 7h
OraSure Technologies Reports Q3 2025 Financial Results

Orasure ( (OSUR) ) has released its Q3 earnings. Here is a breakdown of the information Orasure presented to its investors. Elevate Your Investing Strategy: T...

Seeking Alpha 11h
OraSure Technologies signals return to growth in 2026 while expanding diagnostics portfolio through BioMedomics acquisition

Earnings Call Insights OraSure Technologies signals return to growth in 2026 while expanding diagnostics portfolio through BioMedomics acquisition Nov. 05, 2025...

OraSure Technologies signals return to growth in 2026 while expanding diagnostics portfolio through BioMedomics acquisition
The Motley Fool 12h
OraSure Q3 2025 Earnings Call Transcript

Image source: The Motley Fool. Wednesday, Nov. 5, 2025 at 5 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Carrie Eglinton Manner Chief Finan...

OraSure Q3 2025 Earnings Call Transcript

More OSUR News

TipRanks 13h
OraSure to acquire BioMedomics, expanding diagnostic portfolio

OraSure (OSUR) announced it signed a definitive agreement to acquire BioMedomics. The company said the transaction expands its diagnostic portfolio by adding Si...

People also own

Based on the portfolios of people who own OSUR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.